• TNBC Patient Given Investigative Antibody, Leronlimab, Under Emergency Exception
  • FDA to Review Nerlynx Combo as Third-line Treatment for HER2-positive Metastatic Breast Cancer
  • Music Helps Ease Pain and Fatigue of Breast Cancer, Study Shows
  • Cancer by the Numbers
  • Nerlynx Granted FDA’s Orphan Drug Status for Treating Breast Cancer with Brain Metastases
  • Longer Use of Hormone Replacement Therapy Linked to Greater Breast Cancer Risk in Study
  • FDA Urges Inclusion of Men in Clinical Trials for Breast Cancer Treatment
  • Tecentriq-Abraxane Combo OK’d in EU to Treat Certain Advanced Triple-negative Breast Cancers
  • USPSTF Updates Recommendations on Testing for BRCA-related Cancers in Women
  • 10 Commandments for Surviving Breast Cancer
  • Grant to Fund CAR T-cell Trial for HER2-Positive BC with Brain Metastases
  • Oral Paclitaxel Combo Leads to Better Response Rates Than IV Therapy in MBC, Data Shows